Anti-inflammatoires

EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult CF Patients

Etude : CTX-4430
Type d'étude : Modulateur du CFTR
Titre : A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Phase : 2
Promoteurs :

Age : 18 Years to 30 Years
Lien internet : https://clinicaltrials.gov/ct2/show/NCT02443688